B-Cell and T-Cell Epitopes in Anti-factor VIII Immune Responses
Identifieur interne : 002322 ( Istex/Curation ); précédent : 002321; suivant : 002323B-Cell and T-Cell Epitopes in Anti-factor VIII Immune Responses
Auteurs : Kathleen P. Pratt [États-Unis] ; Arthur R. Thompson [États-Unis]Source :
- Clinical Reviews in Allergy & Immunology [ 1080-0549 ] ; 2009-10-01.
English descriptors
Abstract
Abstract: Adequate hemostasis is achieved for many hemophilia A patients by infusion of plasma-derived or recombinant factor VIII (FVIII), but unfortunately, a significant subset of patients develop an immune response in which anti-FVIII antibodies, referred to clinically as “inhibitors,” interfere with its procoagulant activity. Inhibitors are the subset of anti-FVIII antibodies that bind to surfaces on FVIII (B-cell epitopes) that are important for its proper functioning in coagulation. Less antigenic FVIII molecules may be designed by identifying and then modifying the amino acid sequences of inhibitor B-cell epitopes. Conversely, characterization of these epitopes can yield important information regarding functionally important surfaces on FVIII. The production of inhibitor antibodies is driven by T cells. T cells recognize FVIII as foreign when FVIII-derived peptides bind to major histocompatibility complex (MHC) class II molecules on the surface of antigen-presenting cells. The class II–peptide complexes must then be recognized by T-cell receptors (TCRs). T-cell stimulation requires sustained association of antigen-presenting cells and T cells through formation of a class II–peptide–TCR complex, and peptide sequences that mediate this association are termed “T-cell epitopes.” MHC class II tetramers that bind FVIII-derived peptides and recognize antigen-specific TCRs are proving useful in the characterization of human leukocyte antigen-restricted T-cell responses to FVIII.
Url:
DOI: 10.1007/s12016-009-8120-7
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: Pour aller vers cette notice dans l'étape Curation :002322
Links to Exploration step
ISTEX:B7EC6E591B22233D0A7F133465CA9E6E14908A0DLe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">B-Cell and T-Cell Epitopes in Anti-factor VIII Immune Responses</title>
<author><name sortKey="Pratt, Kathleen P" sort="Pratt, Kathleen P" uniqKey="Pratt K" first="Kathleen P." last="Pratt">Kathleen P. Pratt</name>
<affiliation wicri:level="1"><mods:affiliation>Puget Sound Blood Center, 921 Terry Ave, 98104-1256, Seattle, WA, USA</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Puget Sound Blood Center, 921 Terry Ave, 98104-1256, Seattle, WA</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1"><mods:affiliation>Division of Hematology, Dept. Medicine, University of Washington, Seattle, WA, USA</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of Hematology, Dept. Medicine, University of Washington, Seattle, WA</wicri:regionArea>
</affiliation>
<affiliation><mods:affiliation>E-mail: kathleenp@psbcresearch.org</mods:affiliation>
<wicri:noCountry code="no comma">E-mail: kathleenp@psbcresearch.org</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Thompson, Arthur R" sort="Thompson, Arthur R" uniqKey="Thompson A" first="Arthur R." last="Thompson">Arthur R. Thompson</name>
<affiliation wicri:level="1"><mods:affiliation>Puget Sound Blood Center, 921 Terry Ave, 98104-1256, Seattle, WA, USA</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Puget Sound Blood Center, 921 Terry Ave, 98104-1256, Seattle, WA</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1"><mods:affiliation>Division of Hematology, Dept. Medicine, University of Washington, Seattle, WA, USA</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of Hematology, Dept. Medicine, University of Washington, Seattle, WA</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:B7EC6E591B22233D0A7F133465CA9E6E14908A0D</idno>
<date when="2009" year="2009">2009</date>
<idno type="doi">10.1007/s12016-009-8120-7</idno>
<idno type="url">https://api.istex.fr/ark:/67375/VQC-H00V6SSC-K/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">002322</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">002322</idno>
<idno type="wicri:Area/Istex/Curation">002322</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">B-Cell and T-Cell Epitopes in Anti-factor VIII Immune Responses</title>
<author><name sortKey="Pratt, Kathleen P" sort="Pratt, Kathleen P" uniqKey="Pratt K" first="Kathleen P." last="Pratt">Kathleen P. Pratt</name>
<affiliation wicri:level="1"><mods:affiliation>Puget Sound Blood Center, 921 Terry Ave, 98104-1256, Seattle, WA, USA</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Puget Sound Blood Center, 921 Terry Ave, 98104-1256, Seattle, WA</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1"><mods:affiliation>Division of Hematology, Dept. Medicine, University of Washington, Seattle, WA, USA</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of Hematology, Dept. Medicine, University of Washington, Seattle, WA</wicri:regionArea>
</affiliation>
<affiliation><mods:affiliation>E-mail: kathleenp@psbcresearch.org</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Thompson, Arthur R" sort="Thompson, Arthur R" uniqKey="Thompson A" first="Arthur R." last="Thompson">Arthur R. Thompson</name>
<affiliation wicri:level="1"><mods:affiliation>Puget Sound Blood Center, 921 Terry Ave, 98104-1256, Seattle, WA, USA</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Puget Sound Blood Center, 921 Terry Ave, 98104-1256, Seattle, WA</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1"><mods:affiliation>Division of Hematology, Dept. Medicine, University of Washington, Seattle, WA, USA</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of Hematology, Dept. Medicine, University of Washington, Seattle, WA</wicri:regionArea>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Clinical Reviews in Allergy & Immunology</title>
<title level="j" type="abbrev">Clinic Rev Allerg Immunol</title>
<idno type="ISSN">1080-0549</idno>
<idno type="eISSN">1559-0267</idno>
<imprint><publisher>Humana Press Inc</publisher>
<pubPlace>New York</pubPlace>
<date type="published" when="2009-10-01">2009-10-01</date>
<biblScope unit="volume">37</biblScope>
<biblScope unit="issue">2</biblScope>
<biblScope unit="page" from="80">80</biblScope>
<biblScope unit="page" to="95">95</biblScope>
</imprint>
<idno type="ISSN">1080-0549</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">1080-0549</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>B-cell epitopes</term>
<term>Hemophilia A</term>
<term>Inhibitory antibody</term>
<term>T-cell immune responses</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Abstract: Adequate hemostasis is achieved for many hemophilia A patients by infusion of plasma-derived or recombinant factor VIII (FVIII), but unfortunately, a significant subset of patients develop an immune response in which anti-FVIII antibodies, referred to clinically as “inhibitors,” interfere with its procoagulant activity. Inhibitors are the subset of anti-FVIII antibodies that bind to surfaces on FVIII (B-cell epitopes) that are important for its proper functioning in coagulation. Less antigenic FVIII molecules may be designed by identifying and then modifying the amino acid sequences of inhibitor B-cell epitopes. Conversely, characterization of these epitopes can yield important information regarding functionally important surfaces on FVIII. The production of inhibitor antibodies is driven by T cells. T cells recognize FVIII as foreign when FVIII-derived peptides bind to major histocompatibility complex (MHC) class II molecules on the surface of antigen-presenting cells. The class II–peptide complexes must then be recognized by T-cell receptors (TCRs). T-cell stimulation requires sustained association of antigen-presenting cells and T cells through formation of a class II–peptide–TCR complex, and peptide sequences that mediate this association are termed “T-cell epitopes.” MHC class II tetramers that bind FVIII-derived peptides and recognize antigen-specific TCRs are proving useful in the characterization of human leukocyte antigen-restricted T-cell responses to FVIII.</div>
</front>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Istex/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002322 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd -nk 002322 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= MersV1 |flux= Istex |étape= Curation |type= RBID |clé= ISTEX:B7EC6E591B22233D0A7F133465CA9E6E14908A0D |texte= B-Cell and T-Cell Epitopes in Anti-factor VIII Immune Responses }}
This area was generated with Dilib version V0.6.33. |